Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development

被引：0

作者：

Li, Rui ^{[1
]}

Craig, Morgan ^{[2
,3
]}

D'Argenio, David Z. ^{[4
]}

Betts, Alison ^{[5
]}

Mager, Donald E. ^{[6
,7
]}

Maurer, Tristan S. ^{[1
]}

机构：

[1] Pfizer Inc, Translat Modeling & Simulat, Med Design, Cambridge, MA 02139 USA

[2] Univ Montreal, Dept Math & Stat, Montreal, PQ, Canada

[3] Sainte Justine Univ Hosp Res Ctr, Montreal, PQ, Canada

[4] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA USA

[5] Appl BioMath LLC, Concord, MA USA

[6] Univ Buffalo, State Univ New York, Dept Pharmaceut Sci, Buffalo, NY USA

[7] Enhanced Pharmacodynam LLC, Buffalo, NY USA

来源：

FRONTIERS IN PHARMACOLOGY | 2023年 / 14卷

关键词：

drug discovery; modeling and simulation; decision-making; preclinical-to-clinical translation; preclinical stage;

D O I：

10.3389/fphar.2023.1184914

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：3

共 15 条

[1] Minimal Physiologically-Based Pharmacokinetic (mPBPK) Metamodeling of Target Engagement in Skin Informs Anti-IL17A Drug Development in Psoriasis [J].

Ayyar, Vivaswath S. ;

Lee, Jong Bong ;

Wang, Weirong ;

Pryor, Meghan ;

Zhuang, Yanli ;

Wilde, Thomas ;

Vermeulen, An .

FRONTIERS IN PHARMACOLOGY, 2022, 13

[2] Translational Pharmacokinetic-Pharmacodynamic Modeling of NaV1.7 Inhibitor MK-2075 to Inform Human Efficacious Dose [J].

Ballard, Jeanine E. ;

Pall, Parul S. ;

Vardigan, Joshua ;

Zhao, Fuqiang ;

Holahan, Marie A. ;

Zhou, Xiaoping ;

Jochnowitz, Nina ;

Kraus, Richard L. ;

Klein, Rebecca M. ;

Henze, Darrell A. ;

Houghton, Andrea K. ;

Burgey, Christopher S. ;

Gibson, Christopher ;

Struyk, Arie .

FRONTIERS IN PHARMACOLOGY, 2021, 12

[3] Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies [J].

Bansal, Loveleena ;

Nichols, Eva-Maria ;

Howsmon, Daniel P. ;

Neisen, Jessica ;

Bessant, Christina M. ;

Cunningham, Fraser ;

Petit-Frere, Sebastien ;

Ludbrook, Steve ;

Damian, Valeriu .

FRONTIERS IN PHARMACOLOGY, 2022, 13

[4] PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer's disease [J].

Bloomingdale, Peter ;

Bumbaca-Yadav, Daniela ;

Sugam, Jonathan ;

Grauer, Steve ;

Smith, Brad ;

Antonenko, Svetlana ;

Judo, Michael ;

Azadi, Glareh ;

Yee, Ka Lai .

FRONTIERS IN PHARMACOLOGY, 2022, 13

[5] Development and Evaluation of Competitive Inhibitors of Trastuzumab-HER2 Binding to Bypass the Binding-Site Barrier [J].

Bordeau, Brandon M. ;

Abuqayyas, Lubna ;

Nguyen, Toan D. ;

Chen, Ping ;

Balthasar, Joseph P. .

FRONTIERS IN PHARMACOLOGY, 2022, 13

[6] Computational translation of genomic responses from experimental model systems to humans [J].

Brubaker, Douglas K. ;

Proctor, Elizabeth A. ;

Haigis, Kevin M. ;

Lauffenburger, Douglas A. .

PLOS COMPUTATIONAL BIOLOGY, 2019, 15 (01)

[7] Model-informed target identification and validation through combining quantitative systems pharmacology with network-based analysis [J].

Chelliah, Vijayalakshmi ;

van der Graaf, Piet H. .

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (04) :399-402

[8] Predictive Simulations in Preclinical Oncology to Guide the Translation of Biologics [J].

Dong, Shujun ;

Nessler, Ian ;

Kopp, Anna ;

Rubahamya, Baron ;

Thurber, Greg M. M. .

FRONTIERS IN PHARMACOLOGY, 2022, 13

[9] Physiological Considerations for Modeling in vivo Antibody-Target Interactions [J].

Dunlap, Tyler ;

Cao, Yanguang .

FRONTIERS IN PHARMACOLOGY, 2022, 13

[10] A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs [J].

Kapitanov, Georgi I. ;

Chabot, Jeffrey R. ;

Narula, Jatin ;

Roy, Mahua ;

Neubert, Hendrik ;

Palandra, Joe ;

Farrokhi, Vahid ;

Johnson, Jay S. ;

Webster, Robert ;

Jones, Hannah M. .

FRONTIERS IN BIOINFORMATICS, 2021, 1

← 1 2 →